维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Van Vollenhoven RF"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue显示文摘	Van Vollenhoven RF	2007	Ann Rheum Dis2007，66，：	1
2	Biologics in SLE: towards new approaches显示文摘	Van Vollenhoven RF Parodis I Levitsky A	2013	Best Pract Res Clin Rheu- matol2013，27，：	1
3	Tofacitinib or adalimumab versus placebo in rheumatoid arthritis显示文摘	van Vollenhoven RF Fleischmann R Cohen S	2012	N Engl J Med2012，367，6：	1
4	Tofacitinib or adalimumab versus placebo in rheumatoid arthritis 显示文摘	van Vollenhoven RF Fleischmann R Cohen S	2012	N Engl J Med2012，367，6：	1
5	Tofacitinibor adalimumab versus placebo in rheumatoid arthritis显示文摘	van Vollenhoven RF Fleischmann R Cohen S	2012	N Engl JMed2012，367，6：	1
6	Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with thetime since start of treatment? 显示文摘	Askling J van Vollenhoven RF Granath F	2009	Arthritis Rheum2009，60，：	1
7	Biologics in SLE: towards new approaches 显示文摘	Van Vollenhoven RF Parodis I Levitsky A	2013	Best Pract Res Clin Rheuma2013，27，：	1
8	Tofacitinib or adalimumab versus placebo in rheumatoid arthritis显示文摘	Van Vollenhoven RF Fleischmann R Cohen S		0，，06：	1
9	Tofacitinib or adalimumab versus placebo in rheumatoid ar- thritis显示文摘	VAN VOLLENHOVEN RF FLEISCHMANN R COHEN S	2012	N Engl J Med2012，367，6：	1
10	Dehydroepiandrosterone in systemic lupus erythematosus显示文摘	van Vollenhoven RF	2000	Rheuma Dis Clin North America2000，26，2：	1
11	Treat-to-target in systemic lupus erythematosus:recommendations from an international task force显示文摘	van Vollenhoven RF Mosca M Bertsias G	2014	Ann Rheum Dis2014，73，6：	1
12	Treat-to- target in systemic lupus erythematosus: recommendations from an international task force显示文摘	van Vollenhoven RF Mosca M Bertsias G	2014	Ann Rheum Dis2014，73，6：	1
13	Infliximab dosage and infusion frequency in clinical practice:experiences in the Stockholm biologics registry STURE显示文摘	Van Vollenhoven RF Klareskog L	2007	Scand J Rheum2007，36，6：	1
14	Tofaci-tinib or adalimumab versus placebo in rheumatoid arthritis 显示文摘	Van Vollenhoven RF Fleischmann R Cohen S	2012	NEngl J Med2012，367，6：	1
15	Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus:a doubleblind,randomized,placebo-controlled trial显示文摘	Petri MA Lahita RG Van Vollenhoven RF	2002	Arthritis Rheum2002，46，7：	1
16	Addition of inflix- imab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis( swefot tri-al) :l-year results of a randomised triM显示文摘	van Vollenhoven RF Ernestam S Geborek P	2009	Lancet2009，374，：	1
17	VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype 显示文摘	Bhat NM Lee LM van Vollenhoven RF	2002	J Rheumato12002，29，10：	1
18	Currentevidence for the management of rheumatoid arthritis with biological disease-modifying anti-rheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA显示文摘	Nam JL Winthrop KL van Vollenhoven RF	2010	Ann Rheum Dis2010，69，6：	1
19	Tofacitinib or adalimumab versus placebo in rheumatoid arthritis 显示文摘	VAN VOLLENHOVEN RF FLEISCHMANN R COHEN S		N Engl J Med0，367，6：	1
20	Current evidence for the management of rheumatoid arthritis with biological disease - modi- fying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA 显示文摘	Nam JL Winthrop KL van Vollenhoven RF	2010	Ann Rheum Dis2010，69，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示